V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190007517 | 190004453 | 1.68 | 68.5 | Palliative (P) | 2006-10-25 | 2016-11-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100345861 |
| 190007518 | 190004454 | 0 | 55 | Palliative (P) | 2018-09-13 | 2018-09-13 | CARBOPLATIN + GEMCITABINE | 01 | N | CAPECITABINE + CISPLATIN | 100460744 |
| 190007520 | 190004455 | 1.82 | null | Curative (C) | 2017-03-09 | 2017-06-17 | Docetaxel | 01 | N | NOT MATCHED | 100427636 |
| 190007521 | 190004456 | 1.73 | 61.5 | Palliative (P) | 2020-10-28 | 2021-05-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | TRIAL UNSPECIFIED | 101655712 |
| 190007531 | 190004457 | 0 | 67.4 | Curative (C) | 2017-06-15 | 2017-06-22 | CARBOPLATIN + GEMCITABINE | 02 | N | CAPECITABINE | 101170974 |
| 190007533 | 190004458 | 1.6 | 65 | Neo-adjuvant (N) | 2019-02-12 | 2019-02-12 | Fulvestrant + Ribociclib | Y | Y | CAPECITABINE + OXALIPLATIN | 101565691 |
| 190007546 | 190004459 | 1.76 | 64 | Palliative (P) | 2018-10-30 | 2019-03-21 | OST Rel Ifosfamide Etoposide Mtx | Y | null | RUCAPARIB | 101183946 |
| 190007549 | 190004460 | 1.71 | 12.8 | Neo-adjuvant (N) | 2016-07-20 | 2016-07-20 | Cisplatin 7 day | 02 | N | CISPLATIN | 100036815 |
| 190007561 | 190004462 | 1.71 | null | Adjuvant (A) | 2016-06-27 | 2016-07-05 | VAI (Ifos 3g/m2) | 02 | null | CISPLATIN + ETOPOSIDE | 100883797 |
| 190007566 | 190004463 | 0 | 28 | Curative (C) | 2018-11-26 | 2018-11-26 | Trial Unspecified | N | Y | TEMOZOLOMIDE | 100595628 |
| 190007571 | 190004464 | 0 | 36.5 | Neo-adjuvant (N) | 2016-12-18 | 2017-01-03 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 101763490 |
| 190007573 | 190004465 | 1.5 | 61.8 | 03 | 2017-02-22 | 2017-05-21 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | CISPLATIN + RT | 100858964 |
| 190007576 | 190004466 | null | 72 | Palliative (P) | null | 2021-12-03 | Cisplatin + Radiotherapy | null | null | CISPLATIN | 100302685 |
| 190007577 | 190004467 | 1.73 | null | null | 2019-01-13 | 2019-01-17 | Methotrexate High Dose (3g/m2) | 02 | N | CISPLATIN + FLUOROURACIL | 101257714 |
| 190007582 | 190004468 | 1.56 | 86.6 | Palliative (P) | 2020-09-08 | 2020-09-08 | Bevacizumab 7.5mg/kg | 01 | N | FLUOROURACIL + IRINOTECAN | 100840536 |
| 190007589 | 190004469 | 1.74 | 71.8 | Curative (C) | 2018-01-10 | 2018-01-10 | TEMOZOLOMIDE | 02 | Y | EVEROLIMUS | 101819953 |
| 190007598 | 190004470 | 1.51 | 108 | Palliative (P) | 2017-12-30 | 2018-03-30 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | null | PACLITAXEL | 101687459 |
| 190007600 | 190004471 | null | 78.6 | Palliative (P) | null | 2018-07-11 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100044675 |
| 190007616 | 190004472 | 1.77 | 62.3 | Palliative (P) | null | 2018-07-05 | Ribociclib | N | N | LANREOTIDE | 100803791 |
| 190007621 | 190004473 | 1.67 | 59.2 | Adjuvant (A) | 2017-07-01 | 2017-07-09 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN | 100261518 |
| 190007623 | 190004474 | null | 86 | Curative (C) | 2017-05-09 | 2017-12-17 | LIPOSOMAL DOXORUBICIN | 01 | N | CARBOPLATIN + GEMCITABINE | 100179928 |
| 190007628 | 190004475 | 1.5 | 63.4 | null | 2018-05-17 | 2018-10-06 | EW EuroEwing 2012 Arm A VIDE | 02 | N | CISPLATIN + RT | 101797458 |
| 190007632 | 190004476 | 1.85 | 40.5 | Curative (C) | 2016-04-14 | 2016-05-03 | Etoposide + Ifosfamide (5 days) | 01 | null | ETOPOSIDE + IFOSFAMIDE | 100557877 |
| 190007634 | 190004477 | 0 | 47.3 | Neo-adjuvant (N) | null | 2016-03-21 | Ifosfamide | 02 | null | GEMCITABINE | 100639159 |
| 190007635 | 190004478 | 1.78 | 45 | Curative (C) | 2015-08-27 | 2016-02-06 | CARBOPLATIN + PACLITAXEL | null | null | CARBOPLATIN + PACLITAXEL | 100693012 |
| 190007636 | 190004479 | 1.65 | 80.4 | null | 2019-01-28 | 2019-01-29 | Cisplatin | 02 | N | CISPLATIN | 100791240 |
| 190007642 | 190004480 | 1.76 | 35 | Neo-adjuvant (N) | 2018-12-22 | 2018-12-22 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | null | CAPECITABINE + STREPTOZOCIN | 100590887 |
| 190007644 | 190004481 | null | 112 | Neo-adjuvant (N) | 2018-03-19 | 2018-04-09 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CISPLATIN + GEMCITABINE | 100982277 |
| 190007645 | 190004482 | 1.57 | 64.65 | Adjuvant (A) | 2016-07-28 | 2016-08-07 | FCarboSt | 01 | N | CAPECITABINE + CARBOPLATIN | 100261474 |
| 190007649 | 190004483 | 1.79 | 83.8 | Palliative (P) | 2017-03-29 | 2017-04-20 | Etoposide + Ifosfamide + HD Mtx | Y | N | PEMBROLIZUMAB | 100001004 |
| 190007654 | 190004484 | 0 | 47.9 | null | 2017-05-29 | 2017-06-01 | EW EuroEwing 99 : VIDE | 02 | N | CISPLATIN + GEMCITABINE | 100572959 |
| 190007655 | 190004485 | 1.73 | 30.5 | Palliative (P) | 2021-08-25 | 2021-09-08 | OST Euramos 1 Closed Trial - IE | N | N | FULVESTRANT + PALBOCICLIB | 100132752 |
| 190007659 | 190004486 | 1.73 | 66.7 | null | 2017-03-04 | 2017-03-05 | Capecitabine | 02 | N | DOCETAXEL | 101676691 |
| 190007661 | 190004487 | 1.71 | 77 | Neo-adjuvant (N) | 2016-04-08 | 2016-11-18 | Carbo F | 02 | N | MAP | 101801274 |
| 190007663 | 190004488 | 1.74 | 88.25 | Neo-adjuvant (N) | 2018-09-22 | 2018-11-02 | MAP | 02 | N | ATEZOLIZUMAB | 101728913 |
| 190007666 | 190004489 | 1.52 | 49.8 | Palliative (P) | 2017-04-11 | 2017-04-11 | DHAP | 02 | null | CARBOPLATIN + ETOPOSIDE | 100795617 |
| 190007671 | 190004490 | 1.88 | 96.6 | Neo-adjuvant (N) | 2019-05-15 | 2019-05-17 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100387549 |
| 190007678 | 190004491 | 1.8 | 64.2 | null | 2016-06-22 | 2016-06-24 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 101435177 |
| 190007680 | 190004492 | 1.72 | 123.4 | Palliative (P) | 2016-07-29 | 2016-09-23 | EW EuroEwing 2012 Arm A VAI | 02 | null | IPILIMUMAB + NIVOLUMAB | 100528330 |
| 190007686 | 190004493 | 1.86 | 12.5 | null | 2020-01-16 | 2020-01-28 | GEMCITABINE + NAB PACLITAXEL | 02 | N | ICON TRIAL | 101026186 |
| 190007695 | 190004494 | null | 83.6 | Curative (C) | 2019-12-22 | 2019-12-22 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 101776140 |
| 190007697 | 190004495 | 1.64 | null | null | 2019-10-16 | 2019-10-16 | EW Rel Irinotecan & Temozolomide | 02 | N | PEMBROLIZUMAB | 100118538 |
| 190007701 | 190004496 | 1.58 | 74.7 | Curative (C) | 2016-06-16 | 2016-10-13 | Cyclophosphamide oral | 02 | N | EW EUROEWING 2012 ARM A VAI | 100415934 |
| 190007711 | 190004497 | 1.89 | 62.6 | Palliative (P) | 2018-05-31 | 2018-06-19 | Cyclophosphamide + Topotecan | 02 | N | CAPECITABINE + OXALIPLATIN | 101676266 |
| 190007716 | 190004498 | 1.78 | 69 | Palliative (P) | null | 2020-02-02 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | GEMCARBO | 101506535 |
| 190007727 | 190004499 | 1.8 | 104 | Neo-adjuvant (N) | 2018-11-17 | 2018-12-13 | CNS HGG Temozolomide maintenance | 02 | null | CISPLATIN + RT | 101212824 |
| 190007733 | 190004500 | 1.81 | 26.1 | Adjuvant (A) | 2018-01-01 | 2018-03-06 | Cisplatin + Radiotherapy | null | null | TRIAL UNSPECIFIED | 100681728 |
| 190007740 | 190004501 | null | 32.3 | Curative (C) | 2016-07-13 | 2016-07-19 | Cisplatin 7 day | N | Y | CISPLATIN | 100979640 |
| 190007742 | 190004502 | 0 | 24.7 | Palliative (P) | null | 2019-03-20 | Cisplatin | null | null | CISPLATIN | 100117908 |
| 190007749 | 190004503 | 1.85 | 21 | Palliative (P) | 2021-02-06 | 2021-02-11 | VAI (Ifos 3g/m2) | 02 | null | CAPECITABINE + GEMCITABINE | 100048445 |